GLYCINE, N-(PHOSPHONOMETHYL)-, POTASSIUM SALT, 95.0%, 5g

Ethyl 2-(4-oxocyclohexyl)propanoate, 98%, 1g

2-Boronoterephthalic acid, 98%, 100mg

TERT-BUTYL N-[(4,4-DIMETHYLPYRROLIDIN-3-YL)METHYL]CARBAMATE, 95.0%, 500mg

benzyl (3R)-3-hydroxy-3-methylpiperidine-1-carboxylate, 97.0%, 1g

4-FLUOROBENZYL CARBAMIMIDOTHIOATE HCL, 95.0%, 1g

(1-((Dimethylamino)methyl)cyclopropyl)methanol, 95%, 100mg

trans-4-[Bis(phenylmethyl)amino]cyclohexanecarboxylic acid, 97%, 100mg

N-Methyl-1,2-phenylenediamine Dihydrochloride>98.0%(HPLC)(T)25g

5-BROMO-4-CHLORO-2-(2,5-DIMETHYL-1H-PYRROL-1-YL)-6-METHYLPYRIMIDINE, 95.0%, 1g

boc-asp(ome)-oh DCHA salt, 95.0%, 5g

3-(5-Bromothiophen-2-yl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole, 5g

Báscula analítica y de precisión serie Entris® II Modelos con ajuste interno, no certificados, 0,0001 g, 220 g, BCE224i-1S (W)